Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development.

Area of Science:

• Cardiology
• Molecular Biology
• Pathophysiology

Background:

• Cardiac hypertrophy is an adaptive response to increased workload, aiming to reduce ventricular wall stress.
• Persistent stimuli can cause pathological hypertrophy, leading to heart failure, impaired function, and increased mortality.
• Diabetic cardiomyopathy involves pathological hypertrophy driven by insulin resistance, hyperglycemia, and associated metabolic and inflammatory changes.

Purpose of the Study:

• To review the molecular mechanisms underlying pathological cardiac hypertrophy.
• To explore how these mechanisms contribute to conditions like diabetic cardiomyopathy.
• To identify potential therapeutic targets for preventing and reversing cardiac hypertrophy.

Main Methods:

• Literature review of molecular mechanisms in pathological cardiac hypertrophy.
• Analysis of pathophysiological pathways including cell death, fibrosis, and metabolic alterations.
• Examination of the role of insulin resistance and hyperglycemia in diabetic cardiomyopathy.

Main Results:

• Pathological hypertrophy involves complex mechanisms: cell death, fibrosis, mitochondrial dysfunction, altered metabolism, and impaired quality control.
• Fetal gene reactivation, sarcomere disorganization, and inadequate angiogenesis are key features.
• Diabetic cardiomyopathy highlights the impact of metabolic dysregulation on cardiac remodeling.

Conclusions:

• Understanding the molecular basis of pathological hypertrophy is crucial for therapeutic development.
• Targeting specific pathways could offer novel strategies for treating and preventing heart failure.
• Interventions may focus on metabolic correction, improving protein/mitochondrial quality, and modulating inflammatory responses.